Endocrine Today

Endocrine Today aims to be the leading global resource for endocrine specialists. It provides up-to-date, precise, and reliable reports on clinical matters, socioeconomic issues, and industry news. Additionally, it shares important clinical information regarding medical treatments to enhance patient care.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#61003

United States

#21938

Health/Health

#505

Traffic sources

Monthly visitors

Articles

Patients need to know about ocular risks related to over-the-counter drugs

1 day ago | healio.com | Justin Cooper

Key takeaways:Misuse of over-the-counter anticholinergics, antihistamines and decongestants is an easily overlooked eye health risk factor. Optometrists should ask patients about their use of over-the-counter drugs. MINNEAPOLIS — Over-the-counter medications can have easily overlooked impacts on eye health if not used appropriately, according to a speaker at Optometry’s Meeting.
Optometry board exams passed at ‘notably lower’ rate than those of other specialties

1 day ago | healio.com | Justin Cooper

Key takeaways: The first-time pass rate for the first part of the NBEO exam fell from 76.9% in 2015 to 66.71% in 2024. The exam’s average first-time pass rate was the lowest of all comparable exams. MINNEAPOLIS — Students pass the National Board of Examiners in Optometry exam at a “notably lower” rate than similar exams in other areas of health care, according to a poster presented at Optometry’s Meeting. The findings come from research that Jeffrey L.
Optometrists have important role in long COVID management

2 days ago | healio.com | Justin Cooper

Key takeaways:The most common ocular manifestations of long COVID are conjunctivitis and dry eye. Optometrists can play an important role as part of a multidisciplinary management team. MINNEAPOLIS — Optometrists have an important part to play in the management of patients with long COVID, according to a speaker at Optometry’s Meeting.
Cardiovascular benefits of oral semaglutide ‘consistent’ in high-risk type 2 diabetes

2 days ago | healio.com | Scott Buzby

Key takeaways: In the SOUL trial, Rybelsus reduced risk for heart events by 14% in patients with diabetes and prior heart and/or kidney disease. New analyses show change in HbA1c or body weight did not impact outcomes. CHICAGO — For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related events, with consistent findings in further analyses, according to new data from the SOUL trial.
ACC guidance permits use of modern medications as first-line therapy for obesity

2 days ago | healio.com | Scott Buzby

ACC guidance permits use of modern medications as first-line therapy for obesity• An ACC panel states modern obesity medications may be considered as first-line therapy for treatment of obesity. • Patients should not be required to ‘try and fail’ lifestyle changes first, the panel wrote. A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may be considered as the first treatment for patients with obesity.
Dyop results differ from traditional visual acuity in dim light, blur

2 days ago | healio.com | Justin Cooper

Key takeaways:Dyop and ETDRS results were comparable under photopic conditions. However, Dyop results were worse under mesopic conditions and better under blur conditions. MINNEAPOLIS — Visual acuity measured with the Dyop test varies significantly from ETDRS results under mesopic and blur conditions, according to a study presented at Optometry’s Meeting. The Dyop (Dynamic Optotype) test consists of two circles viewed on a digital display, one of which is spinning.
Dupilumab outperforms omalizumab in chronic rhinosinusitis with nasal polyps

2 days ago | healio.com | Richard Gawel

Key takeaways:EVEREST represents the first head-to-head study of these biologics for CRSwNP. Differences between the biologics were seen as early as 4 weeks. Greater improvements in lung function were seen with dupilumab. Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, according to an abstract presented at European Academy of Allergy & Clinical Immunology Congress 2025.
Income, education have significant impact on patients with HIV receiving cancer treatment

3 days ago | healio.com | Josh Friedman

Read more Key takeaways: People with HIV had a lower likelihood of receiving treatment for cancer if they lived in areas with low income and low educational attainment. Disparities persisted despite insurance type and treatment center. More than 15% of individuals living with HIV and cancer have not received recommended first-line cancer therapy, according to results of a retrospective analysis.
Deep learning model promising in detecting severe glaucoma

3 days ago | healio.com | Justin Cooper

Key takeaways:The model had an area under the curve of 0.92 in the detection of severe glaucoma. Additional training data could boost the model’s performance in mild to moderate glaucoma. MINNEAPOLIS — A deep learning model trained on fundus photographs showed promise in the detection of severe glaucoma, with lower accuracy in mild to moderate cases, according to a poster presented at Optometry’s Meeting.
Heart disease deaths declined in past 50 years, especially from heart attacks

3 days ago | healio.com | Katie Kalvaitis

Heart disease deaths declined in past 50 years, especially from heart attacks• Overall heart disease mortality among U.S. adults decreased by 66% from 1970 to 2022. • Mortality due to causes other than heart attack increased over time. New data highlight a substantial decline in overall heart disease death rates during the past 50 years, along with a shift in the types of heart disease people are dying from most often.